Tom McCarthy Location
Oxford, United Kingdom
Tom McCarthy Work
- 2021–nowFounder and Chair @ ThirtyFiveBio
- 2017–nowFounder and Chair @ Grey Wolf Therapeutics
- 2017–nowFounder and Chair @ Pathios Therapeutics
- 2016–nowVenture Partner @ Brandon Capital Partners
See more
- 2016–nowChair @ Orbit Discovery
- 2015–nowFounder and Chair @ M:M Bio
- 2017–2020Non Executive Director @ Kea Therapeutics
- 2016–2017Non Executive Director @ Trigemina, Inc.
- 2006–2015President, CEO & Managing Director @ Spinifex Pharmaceuticals Inc and Spinifex Pharmaceuticals Pty Ltd
- 2001–2006VP Drug Development @ Starpharma Holdings Limited
Tom McCarthy Investing
Venture Partner at Brandon Capital Partners
- Stages
- Seed, Pre-seed
- Cheque size
- €92k–€4.6M
- Fund size
- $404.5M
- Freshness
- Verified 2w ago
Tom McCarthy Summary
Tom McCarthy, based in Oxford, United Kingdom, is a Venture Partner at Brandon Capital Partners. Tom McCarthy invests at Seed and Pre-seed, writing €92k–€4.6M cheques. Tom McCarthy brings experience from ThirtyFiveBio, Grey Wolf Therapeutics, Pathios Therapeutics and Orbit Discovery. Tom McCarthy's verified email and contact details are available on Mintround.
How to pitch Tom McCarthy
Tom McCarthy invests through Brandon Capital Partners. Here's how to get on Tom's radar:
- Lead with traction that matters to their focus areas — real metrics, not adjectives.
- Keep it under 150 words with one clear, specific ask.
- Email Tom directly at the verified address — no warm intro required.
Every contact is a verified, deliverable email. How Mintround verifies contacts.
Are you Tom McCarthy? Request removal of this listing.